Stan Thomas’ wife, Monica Melkonian, was one of only nine people in the U.S. confirmed to have died from vaccine-induced immune thrombotic thrombocytopenia, a rare side effect associated with the Johnson & Johnson covid vaccine. For the first time, Thomas shares her story of how excited she was to get the shot, how she died, and why he remains firmly pro-vaccine.
Many of the nearly 17 million U.S. members of J&J Nation, myself included, are wondering whether to set aside the current official guidance and get a second booster. Some experts say: Chill out.
Inoculation rates remain low despite massive outreach efforts and incentives from federal and state programs and Medicaid plan operators, leaving many low-income people vulnerable to the virus.
KHN gives readers a chance to comment on a recent batch of stories.
Clinical trials of covid-19 vaccines excluded pregnant people, which left many women wondering whether to get vaccinated.
Those who are living with disabilities, chronic illnesses or are immunocompromised because of medications or cancer treatment feel that their needs are not being considered as states open back up and lift mask mandates.
As the pandemic wanes, for now, the ever-rising cost of health care is again taking center stage. Meanwhile, a year into the Biden administration, the FDA finally has a Senate-confirmed commissioner, Dr. Robert Califf. Tami Luhby of CNN, Sarah Karlin-Smith of the Pink Sheet, and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Hannah Wesolowski of the National Alliance on Mental Illness, about how the pandemic has worsened the nation’s mental health crisis and what can be done about it.
Nicolas Montero is 16, and that’s old enough to get a vaccine on his own in Philadelphia. Vaccine regulations vary around the country and, in more than a dozen states, teens can consent to their own medical care.
Congress is set to start its once-every-five-years review of the law that authorizes user fees to finance the hiring of personnel to speed the FDA review of drugs. The periodic renewals of “PDUFA” also give lawmakers a chance to make other changes to the agency at the hub of the pandemic. Meanwhile, the FDA could also find itself at the center of the abortion debate and a controversial new medication to treat Alzheimer’s disease. Anna Edney of Bloomberg News, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more.
As some states adopt covid vaccine requirements, not everyone agrees mandates for children are the way forward. Taking a page from history: We have two paths to putting the pandemic behind us: a quicker, more certain one of mandatory vaccination or a stuttering, drawn-out, likely more deadly affair.
